US Stock MarketDetailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist
  • 5.330
  • -0.120-2.20%
Close Apr 26 16:00 ET
  • 5.250
  • -0.080-1.50%
Post 18:37 ET
267.32MMarket Cap-2026P/E (TTM)

Monte Rosa Therapeutics Key Stats

Monte Rosa Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.57

+9.52%

Strong Buy

Mar 31, 2024

Monte Rosa Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 1.736M--
--2024/Q1-- / 1.736M--
--2023/Q40.000 / 15.146M--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 1.736M--
--2024/Q1-- / 1.736M--
--2023/Q40.000 / 15.146M--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Monte Rosa Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg